PATENT CLAIM ANALYSIS

Application Number: 16302158
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Claim (Index 4):
The compound according to  claim 1 , wherein\n R 3  is \u2014(CH 2 ) Y \u2014CONH(C 3-6  carbocyclyl substituted with 0, 1, or 2 R 7 ), \u2014(CH 2 ) Y \u2014CONH(4- to 6-membered heterocyclyl substituted with 0, 1, or 2 R 7 ), or \u2014(CH 2 ) Y \u2014CONR e R 4 ; Y is 1 or 2; and R e  and R 4 , taken together with the atoms to which they are attached, form a 5- or 6-membered azacyclyl, which is substituted with 0, 1, or 2 R 5 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.15152
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13936311', '13944921', '14427105', '14346745', '14390152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662612324031776
- 35 USC 102 Novelty (BERT): 0.5260787822800745
- Combined Prediction Score: 0.7422429873908674
- Mean Citation Score: 302.8511640000001
- Max Citation Score: 311.87286
- Similarity Product: 225.65228716083527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test